Optipharm.CO.LTD Capital Reinvestment Ratio
Optipharm.CO.LTD capital reinvestment ratio. Optipharm.CO.LTD (153710) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩905.29 Million) in capital expenditures (₩130.67 Million). Check cash flow reinvestment rate of Optipharm.CO.LTD to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Optipharm.CO.LTD (2016–2019)
Capital reinvestment ratio of Optipharm.CO.LTD from 2016 to 2019. This chart tracks Optipharm.CO.LTD's Capital Reinvestment Ratio across 4 annual periods. Also explore 153710 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Optipharm.CO.LTD Capital Reinvestment Ratio by Year (2016–2019)
Optipharm.CO.LTD capital reinvestment ratio by year from 2016 to 2019. For the full cash flow conversion analysis, see Optipharm.CO.LTD cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.40x | ₩447.47 Million | ₩626.46 Million | ▲ +730.3% |
| 2018 | 0.17x | ₩1.20 Billion | ₩202.91 Million | ▼ -93.4% |
| 2017 | 2.57x | ₩260.86 Million | ₩670.33 Million | ▲ +464.7% |
| 2016 | 0.46x | ₩861.36 Million | ₩391.95 Million | — |